Trials / Completed

CompletedNCT01490190

Study of the Use of a Contraceptive Vaginal Ring (NuvaRing) in Normal Daily Practice in Indian Women (P07733)

Contraceptive Vaginal Ring Releasing Etonogestrel and Ethinylestradiol (NuvaRing): Cycle Control, Acceptability and Tolerability Study in Indian Women

Status: Completed
Phase: Phase 4
Study type: Interventional
Enrollment: 252 (actual)

Sponsor: Organon and Co · Industry
Sex: Female
Age: 18 Years
Healthy volunteers: Accepted

Summary

This study will collect information on cycle control, acceptability and tolerability of the vaginal contraceptive ring (NuvaRing) as used in normal daily practice by Indian women.

Conditions

Contraception

Interventions

Type	Name	Description
DRUG	Ethinylestradiol + Etonogestrel Vaginal Ring (NuvaRing)	Three cycles of NuvaRing use, each cycle consisting of etonogestrel 0.120 mg and ethinylestradiol 0.015 mg over a period of 21 days followed by 7 ring-free days.

Timeline

Start date: 2011-12-26
Primary completion: 2012-12-05
Completion: 2012-12-05
First posted: 2011-12-12
Last updated: 2024-05-24
Results posted: 2014-01-14

Source: ClinicalTrials.gov record NCT01490190. Inclusion in this directory is not an endorsement.